Bioxytran Inc Balance Sheet Statement

BIXT $0.18 0.0 0.0%

23/02/21

Highly Speculative, Micro Cap, Sucker Stock

Market Cap £12.6m

Enterprise Value £13.7m

Revenue £n/a

Quality

Value

Momentum

StockRank™

To unlock Bioxytran Inc's balance sheet statement please upgrade your membership.

	2014	2015	2016	2017	2018	2019
Period End:	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31
Period Length:	0	0	0	0	0	0
Currency:	USD	USD	USD	USD	USD	USD

Cash
Cash and Short Term Investments
Accounts Receivable - Trade, Net
Total Receivables, Net
Total Inventory
Total Current Assets

Property/Plant/Equipment, Total - Gross
Accumulated Depreciation, Total
Property/Plant/Equipment, Total - Net
Total Assets

Accounts Payable
Payable/Accrued
Accrued Expenses
Notes Payable/Short Term Debt
Other Current Liabilities, Total
Total Current Liabilities

Total Long Term Debt
Total Debt
Total Liabilities

Redeemable Preferred Stock
Common Stock
Additional Paid-In Capital
Retained Earnings (Accumulated Deficit)
Total Equity

Total Liabilities & Shareholders’ Equity
Total Common Shares Outstanding
Total Preferred Shares Outstanding

Unlock Stockopedia Premium for free!

See what it can do for your stockpicking and portfolio at no expense.